Two Sigma Investments, LP Kymera Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$41.6 Billion
Q4 2024

A detailed history of Two Sigma Investments, LP transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 173,753 shares of KYMR stock, worth $6.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

173,753

Previous 270,035 35.66%

Holding current value

$6.4 Million

Previous $12.8 Million 45.31%

% of portfolio

0.02%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$39.06 - $51.84 $3.76 Million - $4.99 Million	-96,282 Reduced 35.66%	173,753 $6.99 Million
Q3 2024 Nov 14, 2024	SELL	$30.16 - $52.4 $2.38 Million - $4.13 Million	-78,883 Reduced 22.61%	270,035 $12.8 Million
Q2 2024 Aug 14, 2024	BUY	$29.85 - $39.42 $6.6 Million - $8.72 Million	221,172 Added 173.13%	348,918 $10.4 Million
Q1 2024 May 15, 2024	SELL	$22.9 - $43.57 $110,332 - $209,920	-4,818 Reduced 3.63%	127,746 $5.14 Million
Q4 2023 Feb 14, 2024	SELL	$10.97 - $26.84 $1.04 Million - $2.54 Million	-94,675 Reduced 41.66%	132,564 $3.38 Million
Q3 2023 Nov 14, 2023	BUY	$13.9 - $23.88 $555,096 - $953,647	39,935 Added 21.32%	227,239 $3.16 Million
Q2 2023 Aug 14, 2023	SELL	$22.4 - $34.92 $1.24 Million - $1.93 Million	-55,208 Reduced 22.77%	187,304 $4.31 Million
Q1 2023 May 15, 2023	BUY	$24.84 - $38.75 $3.07 Million - $4.78 Million	123,465 Added 103.71%	242,512 $7.19 Million
Q4 2022 Feb 14, 2023	SELL	$19.57 - $30.92 $202,040 - $319,218	-10,324 Reduced 7.98%	119,047 $2.97 Million
Q3 2022 Nov 14, 2022	SELL	$20.91 - $34.27 $304,993 - $499,862	-14,586 Reduced 10.13%	129,371 $2.82 Million
Q2 2022 Aug 15, 2022	BUY	$14.13 - $42.55 $1.24 Million - $3.73 Million	87,633 Added 155.59%	143,957 $2.84 Million
Q1 2022 May 16, 2022	BUY	$35.3 - $64.68 $1.74 Million - $3.19 Million	49,302 Added 702.11%	56,324 $2.38 Million
Q4 2021 Feb 14, 2022	BUY	$49.91 - $65.56 $350,468 - $460,362	7,022 New	7,022 $446,000
Q2 2021 Aug 16, 2021	SELL	$31.08 - $51.95 $331,468 - $554,046	-10,665 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$35.64 - $85.46 $380,100 - $911,430	10,665 New	10,665 $414,000

Others Institutions Holding KYMR

# of Institutions

186

Shares Held

65.5M

Call Options Held

49.6K

Put Options Held

17K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.01B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Kymera Therapeutics, Inc. Transaction History